Cancel
About Nancy Boman
Nancy Boman is a seasoned Chief Regulatory Officer with a background in medicine and biochemistry, boasting nearly 30 years of experience in the biotech and pharmaceutical industry.
Known information
Nancy Boman holds an M.D. in Human Medicine and a Ph.D. in Biochemistry, along with a B.Sc. in General Science from The University of British Columbia. With nearly three decades of experience, she has developed a deep expertise in regulatory strategy and operations, clinical development, and Chemistry, Manufacturing, and Controls (CMC). Throughout her career, Boman has successfully led over 15 drug marketing applications across various indications, including hematologic malignancies and solid tumors. She has previously held the position of Chief Regulatory Officer at Encoded Therapeutics and AveXis Inc., which is now part of Novartis Gene Therapies. Additionally, her career includes senior roles in regulatory affairs and clinical development at notable companies such as Alder BioPharmaceuticals, Cell Therapeutics, Genentech, and Amgen.
About Adicet Bio
Adicet Bio is a biotechnology company specializing in the development of allogeneic, genetically modified gamma delta T cells for treating autoimmune diseases and cancer, with offices in Redwood City, CA, and Boston, MA.
Report inaccurate information
